SecurityBSX / Boston Scientific Corp.
InstitutionFlagship Harbor Advisors, Llc
Shares15,543
Value $ 508,000
Related 101137AJ6 / Boston Scientific Corp 4.50% Senior Notes 01/15/15
101137AD9 / Boston Scientific Corp 5.125% Notes 01/12/17
101137AB3 / Boston Scientific Corp 5.450% Notes 06/15/14
101137AK3 / Boston Scientific Corp 6.0% Senior Notes 01/15/20
101137AG2 / Boston Scientific Corp 6.4% Senior Notes 6/15/16
101137AL1 / Boston Scientific Corp 7.375% Senior Notes 01/15/40

Flagship Harbor Advisors, Llc reports 1.46% decrease in ownership of BSX / Boston Scientific Corp.

August 14, 2018 - Flagship Harbor Advisors, Llc has filed a 13F-HR form disclosing ownership of 15,543 shares of Boston Scientific Corp. (NYSE:BSX) with total holdings valued at $508,000 USD as of June 30, 2018. Flagship Harbor Advisors, Llc had filed a previous 13F-HR on April 23, 2018 disclosing 15,774 shares of Boston Scientific Corp. at a value of $423,000 USD. This represents a change in shares of -1.46 percent and a change in value of 20.09 percent during the quarter.

Other investors with positions similar to Flagship Harbor Advisors, Llc include CIBC World Markets Inc., Airain ltd, Keybank National Association/oh, Teza Capital Management LLC, Wetherby Asset Management Inc, and Comerica Securities Inc.

Boston Scientific Corp. has declared a standard industrial code (sic) of 3841 which is the "Surgical and Medical Instruments and Apparatus" industry. Flagship Harbor Advisors, Llc's top industries are "Motor Freight Transportation And Warehousing" (sic 42), "Hotels, Rooming Houses, Camps, And Other Lodging Places" (sic 70), and "Oil And Gas Extraction" (sic 13).

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR BOSTON SCIENTIFIC Common Stock 101137107 29.75 15,543 -1.46 508 20.09 -7 92 21.72
2018-03-31 13F-HR BOSTON SCIENTIFIC COM 101137107 26.35 15,774 -2.32 423 1.20 -10 15 3.56
2017-12-31 13F-HR BOSTON SCIENTIFIC COM 101137107 27.56 16,149 -14.47 418 -24.28 -75 -59 -10.64
2017-09-30 13F-HR BOSTON SCIENTIFIC COM 101137107 28.44 18,881 1.52 552 7.39 8 30 5.83
2017-06-30 13F-HR BOSTON SCIENTIFIC COM 101137107 26.02 18,599 14.34 514 29.47 61 56 14.18
2017-03-31 13F-HR BOSTON SCIENTIFIC COM 101137107 16,266 397

Related SEC Filings

BSX / Boston Scientific Corp. / Capital World Investors - SC 13G/A (Passive Investment)

2018-02-16 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Boston Scientific Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 101137107 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of th

BSX / Boston Scientific Corp. / Capital World Investors - SC 13G/A (Passive Investment)

2018-02-16 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Boston Scientific Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 101137107 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of th

BSX / Boston Scientific Corp. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 5 BOSTON SCIENTIFIC CORP COMMON STOCK Cusip #101137107 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #101137107 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 9,999,715 Item 6: 0 Item 7: 157,515,743 Item 8: 0 Item 9: 157,515,743 Item 11: 11.

BSX / Boston Scientific Corp. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 5 BOSTON SCIENTIFIC CORP COMMON STOCK Cusip #101137107 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #101137107 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 9,999,715 Item 6: 0 Item 7: 157,515,743 Item 8: 0 Item 9: 157,515,743 Item 11: 11.

BSX / Boston Scientific Corp. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-08 sec.gov
bostonscientificcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 4 )*       Name of issuer:  Boston Scientific Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  101137107     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:  

Related News Stories

Will Boston Scientific's (BSX) Q3 Earnings Reflect Overall Gain?

9h zacks
Boston Scientific Corporation (BSX - Free Report) is scheduled to report third-quarter 2018 results before the opening bell on Oct 24. (5-0)

Top Analyst Upgrades and Downgrades: Adobe, BofA, Boston Scientific, Facebook, Las Vegas Sands, Merck, Tilray, TJX, Valero and More

2018-10-16 247wallst
Stocks were indicated higher on Tuesday after a follow-on rally failed to hold by Monday’s close. While the market’s all-time highs are still within striking distance, investors have seen lower upside from buying immediately after the big market pullbacks in 2018 than in prior years. And the financial media keeps referring to a “peak cycle” with strong earnings. Now investors have to be considering how they want to position their investments for the rest of the year and into 2019. (67-0)

Here's Why You Should Invest in Boston Scientific Stock Now

2018-10-09 zacks
Boston Scientific Corporation (BSX - Free Report) has been gaining investor confidence on consistently encouraging results. Over the past six months, the company’s share price has outperformed its industry. The stock has gained 27.1% compared with the industry’s 19% rally. Also, the company has outperformed the S&P 500’s 8.7% rise. (4-0)

How Indian stent maker SMT is taking the battle to MNC shores

2018-10-09 moneycontrol
Sahajanand Medical Technologies, or SMT, the Surat-based maker of cardiac stents isn’t content with what it has achieved in India. The management now wants to take the battle to foreign shores. (10-0)

Why Boston Scientific (BSX) is Poised to Beat Earnings Estimates Again

2018-10-05 zacks
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Boston Scientific (BSX - Free Report) , which belongs to the Zacks Medical - Products industry, could be a great candidate to consider. (7-0)



CUSIP: 101137107